baber/WOPTO huggingface dataset:
Patent AU-5103498-A (AU)
Title: Staggered die method and apparatus for necking containers
Inventor: CALEFFI ANTONIO DI
IPC: B21D51/26
Filed: 1997-10-31
Abstract: A necking apparatus for producing a smooth, inwardly tapered necked-in portion on a cylindrical container includes a plurality of necking modules and a turret which is rotatably mounted in each module about an axis of rotation. Each turret includes an upper turret frame which is mounted on the axis of rotation and which can be moved axially relative to the turret and a lower turret frame. A plurality of necking dies are mounted on the upper turret frame, and a plurality of container supports are axially aligned with the necking dies and are mounted on the lower turret frame for axial movement. Each necking die includes a necking portion for engaging and necking a side wall of a container as the aligned container support moves a container toward the necking die. The positions of the necking dies are adjusted by spacers so that the necking portion of each die does not engage the tapered necked-in portion of the container as the container support is moved toward the die.
Patent AU-5127499-A (AU)
Title: High density printed circuit substrate and method of fabrication
Inventor: POMMER RICHARD J
IPC: H05K3/38
Filed: 1999-07-22
Abstract: The present invention is a method and apparatus for providing an electrical substrate. The electrical substrate comprises a dielectric layer having a surface roughness of no greater than 6.0 microns. A first conductive layer is attached to the dielectric layer. In one embodiment, the dielectric layer comprises a laminate that comprises a cloth having a uniform weave and a resin that is consistently impregnated within the uniform weave. A removable layer may be attached to the laminate and removed prior to metallizing of the first conductive layer. Various embodiments are described.
Patent AU-5148393-A (AU)
Title: An anchoring eyelet for tarpaulins and similar coverings
Inventor: SOLBECK PETER
IPC: F16B19/08
Filed: 1993-09-30
Abstract: PCT No. PCT/DK93/00314 Sec. 371 Date Apr. 20, 1995 Sec. 102(e) Date Apr. 20, 1995 PCT Filed Sep. 30, 1993 PCT Pub. No. WO94/09232 PCT Pub. Date Apr. 28, 1994An anchoring eyelet for tarpaulins and similar coverings of a thermoplastic foil material is designed as a substantially annular disc (1) made of plastic. The eyelet has an eyelet opening (2) and is designed in its peripheral part with increased resiliency by means of indentations which may be formed by radially extending resilient tongues (3) or lobes. This avoids any tendency of the eyelets to become detached after being pressed in, while forming notches at heavy loads.
Patent AU-5198779-A (AU)
Title: Prostacyclins
Inventor: SKUBALLA WERNER
IPC: A61K31/557
Filed: 1979-10-19
Abstract: Compounds of the formula   <IMAGE>   wherein R1 is (a) hydrogen, (b) C1-10 alkyl, (c) C1-10 alkyl substituted by halogen; C1-4 alkoxy; C6-10 aryl; C6-10 aryl substituted by 1-3 halogen atoms, a phenyl group, 1-3 C1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C1-4 alkoxy group; di-C1-4-alkylamino; or tri-C1-4-alkylammonium, (d) C4-10 cycloalkyl, (e) C4-10 cycloalkyl substituted by C1-4 alkyl, (f) C6-10 aryl, (g) C6-10 aryl substituted by 1-3 halogen atoms, a phenyl group 1-3 C1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C1-4 alkoxy group, or (h) an aromatic heterocycle of 5 or 6 ring atoms one of which is O, N or S; A is -CH2-CH2-, trans-CH=CH- or -C 3BOND C-; W is hydroxymethylene, RO-methylene, CH3 or CH3,   <IMAGE>   wherein OH or OR is in the  alpha - or  beta -position and R is an in vivo hydrolyzable and physiologically acceptable ether or acyl group which is conventional for modifying OH groups in prostaglandins; D and E together are a direct bond, or D is C1-10 alkylene, C1-10 alkenylene or C1-10 alkynylene or one of these groups substituted by fluorine, and E is oxygen, -C 3BOND C- or a direct bond; R2 is (a) a C1-10 hydrocarbon aliphatic radical, (b) a C6-10 hydrocarbon aliphatic radical substituted by C6-10 aryl or by C6-10 aryl substituted by 1-3 halogen atoms, a phenyl group, 1-3 C1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C1-4 alkoxy group; (c) C4-10 cycloalkyl, (d) C4-10 cycloalkyl substituted by C1-4 alkyl, (e) C6-10 aryl, (f) C6-10 aryl substituted by 1-3 halogen atoms, a phenyl group, 1-3 C1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C1-4 alkoxy group; or (h) an aromatic heterocycle of 5 or 6 ring atoms one of which is O, N or S; and R3 is OH or OR; and, when R1 is hydrogen, the salts thereof with physiologically compatible bases, are effective as antihypertensive, bronchiodilators, thrombocyte aggregation inhibitors, inter alia.
Patent AU-5223793-A (AU)
Title: Method and composition for treatment of metals
Inventor: MUSINGO EDWARD M
IPC: C23C22/44
Filed: 1993-12-08
Abstract: A non-chromate pretreatment for aluminum and zinc-aluminum galvanized steel is disclosed which comprises a polyacrylic acid or homopolymers and copolymers thereof, a molybdate, and a dihydrohexafluo acid.
Patent AU-5462501-A (AU)
Title: Use of alpha-msh and epo for preventing or treating ischemic conditions
Inventor: NIELSEN SOREN
IPC: A61P31/04
Filed: 2001-05-02
Abstract: The present invention relates to a method for treatment or prevention of a non-ischemic condition in one or more organs, the method comprising administering an effective dosage of alpha -MSH and/or an alpha -MSH equivalent and/or EPO and/or an EPO equivalent to a person in need thereof. In particular, the invention relates to the treatment of inflammation under non-ischemic conditions. Non-limiting examples of such conditions are: Asthma, arthritis, psoriasis, infections, systemic lupus erythematosus, Systemic Sclerosis, allergic rhinitis, allergic and non-allergic conjunctivitis. Moreover, inflammatory diseases also include allergic and non-allergic dermatitis.
Patent AU-5548600-A (AU)
Title: A heater unit
Inventor: FELLS ANTHONY CRISPIN
IPC: F24H3/08
Filed: 2000-06-19
Abstract: A heater unit for air handling equipment comprises a peripheral frame 2 across which a plurality of heater tubes 12 extend. The heater tubes 12 have reverse bends, and each extends from an inlet end 6 and an exhaust end 8 disposed on the same side 10 of the frame 2. Respective burner units are provided at the inlet ends of the heater tubes 4. The exhaust ends 8 open into a common manifold from which the combustion gases generated by the burner units are evacuated by means of a fan.The heater unit is suitable for installing in air handling equipment, for example to replace steam or electric heaters, with the frame 2 then serving as part of the ducting of the air handling equipment.
Patent AU-5578594-A (AU)
Title: Silicon alloy, method for producing the alloy and method for production of consolidated products from silicon alloy
Inventor: ESTRADE LEIF L
IPC: C22C28/00
Filed: 1993-11-17
Abstract: The invention relates to a rapidly solidified silicon-based alloy, containing 2 - 40 % by weight Al, 2 - 45 % by weight Ti, 0-10 % by weight of one or more of the elements V, Cr, Fe, Mn, Ni, Co, 0 - 1 % by weight of one or more of the elements B, Sr and P, the rest, except for impurities being silicon in an amount of at least 35 % by weight. The invention further relates to a method for producing such alloys where a molten alloy is provided and is solidified at a rate of solidification of at least 10<3>  DEG C/second. Consolidated products are produced from the silicon based alloy by forming articles from powdered alloy and consolidating the formed articles.
Patent AU-5731690-A (AU)
Title: Remote confinement system
Inventor: WILLIAMSON LON A
IPC: G07C9/00
Filed: 1990-04-26
Abstract: A remote confinement system provides a plurality of different unsupervised tests to determine the presence, identity or conduct of the prisoner. The tests preferably include an RF test performed continuously with an RF transmitter attached to the prisoner and a receiver at the remote location, a schedulable voice test performed to identify a person as the specified prisoner, and a breath alcohol test to determine the prisoner's sobriety. The tests are performed with equipment at the remote location in accordance with test selections and schedules selected in a prior automated communication with a central office computer. Events which include test results are communicated to the central office upon a selectively established communications link to the central office, in reply to which communication information selecting subsequent tests procedures or scheduling is communicated from the host to and stored at the remote location. The information communicated from the host includes an identification code for the transmitter attached to the specified prisoner. The RF test generates a message for transmission to the central unit when the prisoner enters or leaves the remote location, but sounds a warning if the signal is lost and delays transmission of the message to allow the prisoner to return following his departure. This application is a continuation-in-part of U.S. patent application Ser. No. 041,698, filed Apr. 21, 1987, and now U.S. Pat. No. 4,843,377, and entitled "Remoted Confinement System" which is hereby expressly incorporated in its entirety herein by reference.
Patent AU-5760480-A (AU)
Title: Sulphur-containing aromatic diisocyanates
Inventor: SCHWINDT JURGEN
IPC: C08G71/04
Filed: 1980-04-18
Abstract: The invention is directed to new sulfur-containing diisocyanates in which a mercapto, sulfoxo or sulfone group joins two aromatic nuclei together or joins an aromatic nucleus to an aliphatic group and in which at least one of the aromatically bound isocyanate groups is in the ortho-position to the sulfur atom. The invention is also directed to a process for the preparation of these new sulfur-containing diisocyanates and to their use in the isocyanate polyaddition process for the production of polyurethanes.
Patent AU-5804094-A (AU)
Title: Fuel additive compositions containing poly(oxyalkylene) hydroxyaromatic ethers and poly(oxyalkylene) amines
Inventor: CHERPECK RICHARD E
IPC: C10L1/24
Filed: 1993-12-17
Abstract: A fuel additive composition comprising: (a) a poly(oxyalkylene) hydroxyaromatic ether having the formula:   <IMAGE>   or a fuel-soluble salt thereof; where R1 and R2 are each independently hydrogen, hydroxy, lower alkyl having 1 to 6 carbon atoms, or lower alkoxy having 1 to 6 carbon atoms; R3 and R4 are each independently hydrogen or lower alkyl having 1 to 6 carbon atoms; R5 is hydrogen, alkyl having 1 to 30 carbon atoms, phenyl, aralkyl or alkaryl having 7 to 36 carbon atoms, or an acyl group of the formula:   <IMAGE>   where R6 is alkyl having 1 to 30 carbon atoms, phenyl, or aralkyl or alkaryl having 7 to 36 carbon atoms; n is an integer from 5 to 100; and x is an integer from 0 to 10; and (b) a poly(oxyalkylene) amine having at least one basic nitrogen atom and a sufficient number of oxyalkylene units to render the poly(oxyalkylene) amine soluble in hydrocarbons boiling in the gasoline or diesel fuel range.
Patent AU-5972400-A (AU)
Title: Virtual makeover
IPC: G06T11/60
Filed: 2000-06-09
Abstract: A method and apparatus is provided for virtual color makeover of a customer's face. A digital image is taken of the customer's face. Natural skin color is determined by a differential analysis among at least two different sites along the face to identify an area without color. The identified area without color is then used as a basis for projecting the customer's face with the natural skin color. Consultant's choice of preprogrammed color palettes matching the measured natural skin color is then projected on the facial image. A customer's personal choice such as fashion, natural or go-to-work looks can be registered for modifying the consultant's choice color palette. The selected color palette can then be identified as a set of color cosmetic products which are provided to the customer.
Patent AU-6022399-A (AU)
Title: Angiogenically effective unit dose of fgf-2 and method of use
IPC: A61P9/00
Filed: 1999-08-27
Abstract: The present invention has multiple aspects. In particular, in one aspect, the present invention is directed to a unit dose composition comprising 0.2 µg/kg to 48 µg/kg of an FGF-2 of SEQ ID NO: 2, or an angiogenically active fragment or mutein thereof in a pharmaceutically acceptable carrier. In another aspect, the present invention is directed to a method for treating a human patient for coronary artery disease, comprising administering into one or more coronary vessels or a peripheral vein of a human patient in need of treatment for coronary artery disease a safe and angiogenically effective dose of a recombinant FGF-2, or an angiogenically active fragment or mutein thereof. The single unit dose composition of the present invention provides an angiogenic effect in a human CAD patient that lasts six months before re-treatment is required. In another aspect, the present invention is directed to a method of administration which optimizes patient's safety. In this embodiment, fluids, heparin and/or rate of infusion all play a role. In another aspect, the present invention is directed to a pharmaceutical composition comprising a therapeutically effective amount of FGF-2, alone or in combination with heparin, in a therapeutically effective carrier. The magnitude and duration of benefit were unexpected; in addition benefit with the IV route was unexpected.
Patent AU-6111594-A (AU)
Title: Process for the management of transmission errors between a base station and a transcoder in a digital radiocommunication system, corresponding base station and transcoder
Inventor: DUPUY PIERRE
IPC: H04W88/18
Filed: 1994-02-23
Abstract: The invention relates to a method of managing transmission errors between a base station and a transcoder, in a digital radiocommunications system for mobile stations, in which method the transcoder, in the presence of a transmission error, systematically inserts (29, 221, 228) an error message in a frame addressed to the base station without interrupting useful data transmission to the base station, and in which method the base station decides to interrupt data transmission to the transcoder (down direction) and generates an up-direction transmission interruption request when the transmission errors detected in the down direction and/or reported by an error message in the up direction satisfy predetermined conditions. In this way, all call-interruption decisions are centralized in the base station.
Patent AU-6137894-A (AU)
Title: Modular cab and sleeper structural assembly for a truck-tractor vehicle
Inventor: KOSKE CHARLES E
IPC: B62D33/06
Filed: 1994-02-10
Abstract: A modular cab/sleeper structural assembly (31) for a truck-tractor vehicle (30) is provided which improves ride quality and structural integrity without substantially increasing the overall weight or sacrificing any advantages of separate cab and sleeper units. The assembly (31) includes a chassis frame (33) extending substantially longitudinal of the vehicle (30) and a cab unit (35) having a cab structural assembly (37) mounted to the chassis frame (33) by a first mount (42). A sleeper unit (38) having a sleeper structural assembly (40) is mounted to the chassis frame (33) by a second mount (43). A coupling member (41), coupled between the cab structural assembly (37) and the sleeper structural assembly (40) and independent of the chassis frame (33), rigidly couples the sleeper structural assembly (40) and the cab structural assembly (37) together to produce a substantially unified composite structure for increased structural integrity. A method for improving ride quality and structural integrity of the modular cab/sleeper structural assembly (31 ) is also provided.
Patent AU-6380394-A (AU)
Title: Tissue equivalents
Inventor: DAVIES ALBAN
IPC: A61F2/06
Filed: 1994-03-29
Abstract: A method of forming a tissue equivalent is described. A length of polyester tube is threaded over a mandrel (H) and attached at either end by clips at A and D. A block (F) is then screwed into place. The polyester is then pre-soaked by injecting through Tap (2) an acidified collagen solution for approximately one hour. After a suitable period of time the excess solution is aspirated off. Following this stage, a second, alkaline solution is injected into the apparatus which contains smooth muscle cells (SMC). Thus, neutralisation of the collagen impregnated within the fabric of the tube occurs leading to spontaneous fibrillogenesis within the interstices of the cloth, eliminating the risk of delamination. The apparatus is then incubated. The collagen contracts down onto the fabric tube and the cell-impregnated gel becomes incorporated into the presoaked collagen. The pre-impregnated collagen and the collagen provided in the aqueous mixture contract down as one into a coherent whole with the SMC. The tissue equivalent is then lined with endothelial cells and the apparatus again incubated and fed at increasing intraluminal pressures applied either statically or dynamically. This is believed to cause the vessel to become preconditioned to the pressure it will work under as an implant. This allows organization of the basement membrane which in turn promotes EC attachment and theoretically prevents smooth muscle cell hyperplasia.
Patent AU-6440394-A (AU)
Title: Method and device for precipitating crystals from a solution
Inventor: RAGNARSSON SVEN
IPC: B01D9/00
Filed: 1994-03-30
Abstract: A method and a device for recovering crystals from a solution by evaporation with crystallisation in an evaporation plant having at least two stages are disclosed. In the method, the crystallised salt is separated in each evaporation stage (n) from mother liquor and is, in all stages except the first, dissolved to a substantially saturated solution, which is then conducted to the preceding evaporation stage (n-1). The crystallised salt in the first evaporation stage of the plant is collected as final product. The device comprises at least two evaporators (I1, I2, I3) with an inlet (1, 2, 3) for heating medium, and an inlet (6, 11, 14) for the solution to be evaporated, and an outlet (7, 12, 16) for the evaporated solution. The outlet of each evaporator (I1, I2, I3) is provided with separating means (C1, C2, C3) for separating crystals from mother liquor. The inlet of an evaporator (I1, I2...In-1) is connected to the separating means (C2, C3...Cn) of the subsequent evaporator (I2, I3...In) for receiving crystals from the separating means, and to a supply means (5) for liquid which forms, with the crystals, a substantially saturated solution which is to be evaporated. The outlet (10) for crystals from the separating means (C1) of the first evaporator (I1) of the device is the product outlet.
Patent AU-6449800-A (AU)
Title: Method for moulding ophthalmic lenses
Inventor: MERCIER JEAN-LOUIS
IPC: B29C33/38
Filed: 2000-06-20
Abstract: The invention concerns a method for moulding a lens, between a first mould ( 2 ) and a second mould ( 6 ) which consists in: machining at least one of the moulds ( 2 ) into the shape of the lens to be obtained, before moulding. The invention enables to obtain finer lenses, while limiting the required amount of hardenable material for making the lens.
Patent AU-6559300-A (AU)
Title: Actuation and control device for electric switchgear
Inventor: ELLI ENRICO
IPC: H01H33/59
Filed: 2000-06-20
Abstract: An actuation and control device for opening an electric switchgear, for example circuit breakers, disconnectors, etc., particularly for high and medium voltage transmission and/or distribution network. The device allows to improve manoeuvres of the switchgear from both a mechanical and an electrical point of view, and in particular makes it possible to perform the electrical operation in a synchronous and repeatable manner in relation to the network parameters.  <IMAGE>
Patent AU-6570398-A (AU)
Title: On-site sewage treatment and disposal system
Inventor: HASSETT ALAN F
IPC: E03F1/00
Filed: 1998-03-19
Abstract: An on-site sewage treatment and disposal system for areas having a ground water level above a minimum depth below grade is provided. The system includes a perimeter barrier arranged around a selected subterraneal volume. A drainage pipe which is adapted to receive fluid is provided. The drainage pipe is at least partially located within the selected subterraneal volume inside the perimeter barrier. A pump having a gas intake and a discharge side which discharges gas at a pressure greater than atmospheric pressure is also provided. The discharge side of the pump is in fluid communication with the selected subterraneal volume to lower the ground water level within the perimeter barrier to a level at or below the minimum depth below grade. A method for on-site wastewater disposal is also provided utilizing the treatment and disposal system.
Patent AU-6737290-A (AU)
Title: High fidelity hearing aid amplifier
Inventor: KILLION MEAD C
IPC: H03G9/18
Filed: 1990-10-31
Abstract: A high fidelity hearing aid amplifier is operable at a very low battery voltage and includes a single integrated circuit chip which provides a variable gain amplifier and gain control circuitry operative at low signal levels to enhance gain at higher frequencies relative to gain at lower frequencies, such circuitry including a logarithmic rectifier arrangement and a peak detector in a compression ratio control circuit. Operation at a low battery voltage is enhanced through a compression ratio control circuit which provides a level shift between an AC output of the logarithmic rectifier arrangement and the peak detector. Current mirrors are provided to obtained balanced and stable operation, and an arrangement is provided for manual control by a user to obtain an optimum response characteristic.
Patent AU-6830687-A (AU)
Title: Container discharge apparatus
Inventor: ALTHAUS JOHN EDMUND
IPC: F04F1/08
Filed: 1986-12-22
Abstract: PCT No. PCT/AU86/00391 Sec. 371 Date Jun. 24, 1988 Sec. 102(e) Date Jun. 24, 1988 PCT Filed Dec. 22, 1986 PCT Pub. No. WO87/03865 PCT Pub. Date Jul. 2, 1987.Apparatus and method for enabling viscous fluids to be discharged from a container. The container is provided with an outlet positioned for gravity discharge of the contents. Microwave energy is delivered to an inlet opening of the container for the purpose of heating the stored fluids in a controlled area which includes the inlet and outlet. The microwave energy is effective to heat the viscous fluids to a flowable state while fluids are simultaneously discharged from the outlet. The energy level can be controlled based on the level of viscous fluid in the tank so that the viscous fluid is not overheated.
Patent AU-6928887-A (AU)
Title: Sheet moulding compound and an upper layer for it
Inventor: GASSE RENE LEOPOLD EDUARD VAN
IPC: B29C43/30
Filed: 1987-02-26
Abstract: The invention relates to a sheet moulding compound (SMC) comprising a basic layer (3) consisting of thermosetting material, fillers, fibres and customary additves, one side of which is provided with two layers, an intermediate layer (2) and a top layer (1), the intermediate layer of which lies against the basic layer, the intermediate layer comprising at least fibre reinforcement and thermosetting material in a partly cured state and the top layer comprising the same or a different thermosetting material, which is in a cured state to a smaller extent than the first layer. The invention relates also to a sheet-shaped product that can be applied as an upper layer for a moulding compound like a SMC, BMC and DMC, that consists of the above described intermediate layer and top layer.
Patent AU-7069498-A (AU)
Title: Human theta subunit of the gaba-a receptor
Inventor: BONNERT TIMOTHY PETER
IPC: A61K38/00
Filed: 1998-04-24
Abstract: This invention concerns the cloning of a novel cDNA sequence encoding a particular subunit of the human GABAA receptor. In addition, the invention relates to a stable cell line capable of expressing said cDNA and to the use of the cell line in a screening technique for the design and development of subtype-specific medicaments.